In a monumental development for the nation’s ongoing battle against the HIV/Aids epidemic, Uganda has officially marked a significant milestone by launching the long-acting prevention medication known as Lenacapavir. This historic rollout took place in Lira City, signaling a new chapter in the country’s medical strategy to curb infection rates. However, as the medical community celebrates this innovative pharmaceutical advancement, prominent health leaders have issued a stern and urgent warning to the public. These officials emphasize that any sense of complacency among the population could severely undermine the hard-won progress that has been meticulously achieved over several decades of dedicated intervention and advocacy.
